Verify any claim · lenz.io
Claim analyzed
Health“Sharks do not get cancer.”
Submitted by Quick Zebra 4e13
The conclusion
Sharks are not cancer-proof. Authoritative medical sources and peer-reviewed studies document both benign and malignant tumors in sharks and explicitly identify the claim as a myth. Research on low mutation rates or distinctive immune genes may suggest biological differences, but it does not show that sharks never develop cancer.
Caveats
- The claim uses absolute wording; documented cancer cases in sharks are enough to disprove it.
- Evidence about low mutation rates, cartilage, or cancer-related genes does not logically imply zero cancer incidence.
- Cancer in wild sharks may be underdetected, but uncertainty about prevalence is not evidence that sharks do not get cancer.
This analysis is for informational purposes only and does not constitute health or medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before making health-related decisions.
Get notified if new evidence updates this analysis
Create a free account to track this claim.
Sources
Sources used in the analysis
Shark cartilage became popular after a book published in the early 1990s claimed that sharks do not get cancer because they have cartilage instead of bones. However, multiple studies have found that sharks do get cancer, including malignant tumors.
An alleged lack of cancer in sharks constitutes a key justification for its use. Herein, both malignant and benign neoplasms of sharks and their relatives are described, including previously unreported cases from the Registry of Tumors in Lower Animals, and two sharks with two cancers each.
Sharks occupy diverse ecological niches and play critical roles in marine ecosystems, often acting as apex predators. They are considered a slow-evolving lineage and have been suggested to exhibit exceptionally low cancer rates. These two features could be explained by a low nuclear mutation rate. Here, we provide a direct estimate of the nuclear mutation rate in the epaulette shark (Hemiscyllium ocellatum)... Using stringent criteria, we estimate a mutation rate of 7×10−10 per base pair, per generation. This represents one of the lowest directly estimated mutation rates for any vertebrate clade.
Peer-reviewed editorial in the Journal of the National Cancer Institute (2005) explicitly titled 'Sharks do get cancer,' directly refuting the widespread myth that sharks are immune to cancer.
The purpose of this study is to evaluate veterinary records of fish diagnosed with cancer to determine the most common presentation of this disease. While focused on pet fish, it notes documented cases of neoplasia in cartilaginous fish including sharks, confirming cancer occurs in these species.
In this review, we summarize the current state of research into fish-derived cartilage products and their application. It acknowledges scientific literature documenting cancer incidences in sharks, countering outdated myths of cancer-free sharks.
Sharks do, of course, get cancer, and numerous examples of shark cancer have been documented. Brunnschweiler et al. documented a cancerous lesion on the jaw of a bull shark (Carcharhinus leucas) over seven years in a marine reserve, with the affected animal still alive as of the publication date, demonstrating ongoing tumor progression in a free-living wild shark.
A study published Jan. 30 in the journal BMC Genomics provides the first evidence that some shark and ray immunity genes have undergone evolutionary adaptation that may be tied to these novel immune system abilities. Two shark immune genes, legumain and Bag1, stand out. Both of these genes have counterparts in humans, where their overexpression is known to be associated with a range of cancers. The new research shows that these genes in sharks, however, have become modified through evolutionary natural selection.
A UW Carbone Cancer Center researcher studies how shark antibodies, or proteins that keep the body healthy, may be used in humans to guide imaging and treatment of metastatic cancer, indicating ongoing research into shark-derived compounds for cancer applications.
Contrary to the popular belief that sharks are exempt from the consequences of cancer, there are new documented tumors in shark species... cancer does appear in forms popularly called chondromas (cancer of the cartilage)... a great white shark found off the coast of Australia has a 1-foot by 1-foot-wide tumor. Similarly, a mass was also discovered on the head of a bronze whaler shark.
The myth that sharks do not get cancer originated from the 1992 book 'Sharks Don't Get Cancer' by William Lane and Linda Comac, which claimed sharks rarely develop cancer due to compounds in shark cartilage. This book became a commercial driver for shark cartilage supplements marketed as cancer treatments, despite the lack of scientific evidence supporting efficacy. The myth has been repeatedly debunked by peer-reviewed research since the early 2000s.
Scientists have recorded multiple different types of cancers in over 40 species of sharks and their close relatives. Cancers of the nervous system, reproductive organs, endocrine system skeleton and nervous system have been documented in over 20 different species of sharks, including reef sharks, dogfish, catsharks and tiger sharks. People began repeating this myth after a book, entitled 'Sharks Don't Get Cancer' was published in 1992.
Yes. Sharks can get cancer. While it is very tricky for scientists to figure out how often sharks get cancer, there have been multiple cases of sharks with cancer documented in the scientific literature.
At the University of Wisconsin-Madison, students and faculty are learning from sharks everyday which is leading to advancements in cancer research.
What do you think of the claim?
Your challenge will appear immediately.
Challenge submitted!
Continue your research
Verify a related claim next.
Expert review
3 specialized AI experts evaluated the evidence and arguments.
Expert 1 — The Logic Examiner
The logical chain from evidence to claim is straightforward and unambiguous: Sources 1, 2, 4, 5, 6, 7, 10, 12, and 13 directly document malignant and benign tumors in sharks across dozens of species, with the National Cancer Institute and peer-reviewed journals explicitly labeling the 'sharks don't get cancer' claim a myth. The proponent's rebuttal attempts to reframe the absolute claim ('do not get cancer') as a colloquial expression of low incidence, which is a textbook equivocation fallacy — the claim as stated is categorical, not probabilistic, and Sources 3 and 8 address mutation rates and gene evolution, not cancer immunity, making the inference from 'low mutation rate' to 'no cancer' a non sequitur. The opponent correctly identifies this equivocation and the non sequitur, and the evidence pool logically and directly refutes the claim with no significant inferential gaps.
Expert 2 — The Context Analyst
The claim is framed as an absolute (“do not get cancer”) and omits the well-documented reality that sharks develop both benign and malignant tumors, which is explicitly noted by authoritative cancer references and peer-reviewed summaries debunking the myth (Sources 1, 2, 4, 5). Even if some shark lineages may have comparatively low mutation rates or potentially lower cancer incidence (Source 3), that context does not support immunity and does not change the bottom-line truth that sharks can and do get cancer, so the claim is false overall.
Expert 3 — The Source Auditor
The most reliable, independent sources in the pool—National Cancer Institute (Source 1, cancer.gov) and peer‑reviewed biomedical literature indexed on PubMed including Cancer Research (Source 2) and a JNCI editorial summarized on PubMed (Source 4)—explicitly state the “sharks don't get cancer” claim is a myth and document both benign and malignant tumors in sharks. The only nominally supportive item (Source 3) merely reports a low mutation rate and says sharks have been “suggested” to have low cancer rates (not zero), so trustworthy evidence refutes the absolute claim that sharks do not get cancer.
Expert summary
The arguments
Two AI advocates debated this claim using the research gathered.
Argument for
While the evidence is overwhelmingly against this claim, one could argue that Source 3 from PubMed supports the notion that sharks exhibit 'exceptionally low cancer rates' due to one of the lowest nuclear mutation rates ever recorded in any vertebrate, and Source 8 from Cornell University confirms that shark immune genes like legumain and Bag1 have undergone novel evolutionary adaptation specifically tied to cancer-related pathways, suggesting a uniquely robust biological resistance. Therefore, the claim that sharks 'do not get cancer' can be interpreted as a colloquial expression of their extraordinarily rare cancer incidence and exceptional genomic stability, which the scientific literature itself acknowledges as a remarkable biological phenomenon.
The Proponent equivocates by recasting an absolute claim (“do not get cancer”) as a vague colloquialism about rarity, but the record directly contradicts immunity: authoritative reviews and editorials explicitly document malignant tumors in sharks and state the myth is false (Source 1, National Cancer Institute; Source 4, Journal of the National Cancer Institute editorial; Source 2, Cancer Research). Moreover, Source 3 only reports a low mutation rate and notes sharks have merely been “suggested” to have low cancer rates—neither it nor the Cornell news item on gene evolution (Source 8) provides incidence data or overturns the documented existence of shark cancers, so the inference from genomic features to “no cancer” is a non sequitur.
Argument against
The claim is false because authoritative cancer references explicitly state that multiple studies have found sharks develop both benign and malignant tumors, directly debunking the “sharks don't get cancer” myth (Source 1, National Cancer Institute; Source 4, Journal of the National Cancer Institute editorial). Peer-reviewed documentation further describes numerous shark neoplasms—including cases of individual sharks with two separate cancers—showing cancer occurrence is real rather than hypothetical (Source 2, Cancer Research; Source 7, The Shark Trust).
The Opponent conflates the documented occurrence of cancer in sharks with the frequency and biological significance of such occurrences, committing a false equivalence fallacy — the existence of cancer cases does not negate the scientifically acknowledged phenomenon of exceptionally low cancer rates, which Source 3 explicitly attributes to one of the lowest nuclear mutation rates recorded in any vertebrate. Furthermore, the Opponent's reliance on Source 2's registry of neoplasms across diverse shark species fails to account for the broader context provided by Source 8, which confirms that shark immune and cancer-related genes have undergone novel evolutionary adaptation, supporting the interpretation that sharks possess a uniquely robust biological resistance that renders cancer incidence remarkably rare rather than commonplace.